· Daily · Newsletters
Resonance network: Quantum InsiderSpace Insider
Novo Nordisk and AI-focused Valo Health have announced an expanded collaboration to accelerate the discovery and development of treatments for obesity, type 2 diabetes, and cardiovascular disease. The partnership leverages Valo’s Opal Computational Platform™,
The daily briefing on LinkedIn. Free, one tap to follow.
The daily briefing plus the weekly Scale-ups to watch edition. Free, no spam, unsubscribe any time.